BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27995941)

  • 1. Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms.
    Saliba M; Saadeh D; Bouchand F; Davido B; Duran C; Clair B; Lawrence C; Annane D; Denys P; Salomon J; Bernard L; Dinh A
    Spinal Cord; 2017 Feb; 55(2):148-154. PubMed ID: 27995941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood stream infections due to multidrug-resistant organisms among spinal cord-injured patients, epidemiology over 16 years and associated risks: a comparative study.
    Dinh A; Saliba M; Saadeh D; Bouchand F; Descatha A; Roux AL; Davido B; Clair B; Denys P; Annane D; Perronne C; Bernard L
    Spinal Cord; 2016 Sep; 54(9):720-5. PubMed ID: 26882486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
    Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
    Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bloodstream infections in older population: epidemiology, outcome, and impact of multidrug resistance.
    de Laroche M; Fellous L; Salomon E; Saadeh D; Duran C; Bouchand F; Lequintrec JL; Teillet L; Gaillard JL; Seridi Z; Michelon H; Dinh A
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1665-1672. PubMed ID: 33694038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
    Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
    Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study.
    Pilmis B; Alby-Laurent F; Fasola ML; Seegers V; Guery R; Guet-Revillet H; Postaire M; Toubiana J; Bille E; Lortholary O; Zahar JR
    Eur J Pediatr; 2020 Aug; 179(8):1247-1254. PubMed ID: 32080759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
    Gudiol C; Albasanz-Puig A; Laporte-Amargós J; Pallarès N; Mussetti A; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Paz Morales H; Brunel AS; García E; Isler B; Kern WV; Morales I; Maestro-de la Calle G; Montero M; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J;
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and outcomes of antibiotic adequacy for bloodstream infections in veterans with spinal cord injury.
    Evans CT; Burns SP; Chin A; Weaver FM; Hershow RC
    Arch Phys Med Rehabil; 2009 Aug; 90(8):1364-70. PubMed ID: 19651270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
    Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY
    Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel).
    Cattaneo C; Zappasodi P; Mancini V; Annaloro C; Pavesi F; Skert C; Ferrario A; Todisco E; Saccà V; Verga L; Passi A; Da Vià M; Ferrari S; Mometto G; Petullà M; Nosari A; Rossi G
    Ann Hematol; 2016 Dec; 95(12):1955-1963. PubMed ID: 27650830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center.
    Marín M; Gudiol C; Garcia-Vidal C; Ardanuy C; Carratalà J
    Medicine (Baltimore); 2014 May; 93(3):143-149. PubMed ID: 24797169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.
    Adrie C; Garrouste-Orgeas M; Ibn Essaied W; Schwebel C; Darmon M; Mourvillier B; Ruckly S; Dumenil AS; Kallel H; Argaud L; Marcotte G; Barbier F; Laurent V; Goldgran-Toledano D; Clec'h C; Azoulay E; Souweine B; Timsit JF;
    J Infect; 2017 Feb; 74(2):131-141. PubMed ID: 27838521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD; Shorr AF
    J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of prior β-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa.
    Hammer KL; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):87-91. PubMed ID: 27810318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence.
    Recio R; Mancheño M; Viedma E; Villa J; Orellana MÁ; Lora-Tamayo J; Chaves F
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
    Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
    J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and impact of bloodstream infections among kidney transplant recipients: A retrospective single-center experience.
    Shendi AM; Wallis G; Painter H; Harber M; Collier S
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29151282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection.
    Viasus D; Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Chumbita M; Moreno-García E; Fernández-Avilés F; Gutiérrez-Garcia G; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
    Clin Microbiol Infect; 2020 Mar; 26(3):345-350. PubMed ID: 31295551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.